Life Sciences Investment Banking

An experienced team in a vibrant sector.

Raymond James Life Sciences practice provides comprehensive advisory and financing capabilities to innovative businesses in the biotechnology, specialty pharmaceutical and generic pharmaceutical sectors. Companies within the biopharma industry continue to face the disruptive forces that require them to tailor their strategies in the continually evolving business environment. Our team provides our clients with solutions based on our deep relationships with company management teams as well as venture, private equity and public market investors.

Life Sciences Subsector Expertise

  • Biotechnology
  • Specialty Pharmaceuticals

Senior Banking Team

Stu Barich
Stuart Barich
Managing Director
New York
   
Read Bio
Rainer Hepberger
Managing Director
Munich
   
Bio-no-photo
Marwan Kubursi
Managing Director
Toronto
   
David Stubbs
Managing Director
San Francisco
   
Read Bio
George Billington
George Billington
Senior Vice President
New York
   
Deborah Gerewitz
Deborah Gerewitz
Vice President
New York
   
Read Bio
Steven Lowry
Vice President
San Francisco
   
Read Bio

Transaction History

Transaction history may include a transaction completed by a Raymond James banker while at a former firm.

Recent News

Investment Banking  |  April 16, 2019

Raymond James recognized with two deal-of-the-year awards at the annual M&A Advisor Turnaround Awards

Read More about Raymond James recognized with two deal-of-the-year awards at the annual M&A Advisor Turnaround Awards
Equity Research  |  March 13, 2019

Raymond James hires Tavis McCourt as Institutional Equity Strategist

Read More about Raymond James hires Tavis McCourt as Institutional Equity Strategist
Investment Banking  |  January 23, 2019

Raymond James Financial to acquire boutique investment bank Silver Lane Advisors

Read More about Raymond James Financial to acquire boutique investment bank Silver Lane Advisors